DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
9.94
+0.13 (1.34%)
Aug 13, 2025, 4:00 PM - Market closed
DBV Technologies Revenue
DBV Technologies had revenue of $1.47M in the quarter ending June 30, 2025, with 26.18% growth. This brings the company's revenue in the last twelve months to $3.80M, down -72.49% year-over-year. In the year 2024, DBV Technologies had annual revenue of $4.15M, down -73.61%.
Revenue (ttm)
$3.80M
Revenue Growth
-72.49%
P/S Ratio
71.43
Revenue / Employee
$34,545
Employees
110
Market Cap
271.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.15M | -11.58M | -73.61% |
Dec 31, 2023 | 15.73M | 10.88M | 224.69% |
Dec 31, 2022 | 4.84M | -864.00K | -15.14% |
Dec 31, 2021 | 5.71M | -5.57M | -49.38% |
Dec 31, 2020 | 11.28M | -3.43M | -23.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
DBVT News
- 15 days ago - DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report - GlobeNewsWire
- 15 days ago - DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results - GlobeNewsWire
- 16 days ago - Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - GlobeNewsWire
- 22 days ago - DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer - GlobeNewsWire
- 7 weeks ago - DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old - GlobeNewsWire
- 2 months ago - DBV Technologies to Participate in Upcoming EAACI Congress 2025 - GlobeNewsWire
- 2 months ago - DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting - GlobeNewsWire
- 2 months ago - DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document - GlobeNewsWire